Composite Measures in Psoriatic Arthritis: GRAPPA 2008
- 9 February 2010
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 37 (2), 453-461
- https://doi.org/10.3899/jrheum.090956
Abstract
At the 2008 annual meeting of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) in Leeds, UK, members discussed the value and current status of composite measures for the assessment of psoriatic arthritis (PsA). In plenary presentations, examples of composite measures developed for rheumatoid arthritis (RA) and ankylosing spondylitis (AS) were reviewed, followed by a presentation of the assessment of disease activity in systemic lupus erythematosus. Three recently devised composite methods of assessing activity or response in PsA also were presented. Considerable discussion followed in breakout groups, and members agreed that a new composite measure specifically for PsA is necessary. The composite measure should include components that encompass the spectrum of psoriatic disease, i.e., in addition to assessment of peripheral joints, it should include assessment of sacroiliitis, spondylitis, enthesitis, and dactylitis, as well as skin and nail disease.This publication has 12 references indexed in Scilit:
- International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitisArthritis Care & Research, 2009
- Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohortRheumatology, 2008
- Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2008
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2006
- Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remissionAnnals Of The Rheumatic Diseases, 2006
- Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitorsAnnals Of The Rheumatic Diseases, 2006
- BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosusRheumatology, 2005
- Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global AssessmentJournal of the American Academy of Dermatology, 2004
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978